Biogen Inc. (NASDAQ:BIIB) Q4 2019 Results Earnings Conference Call January 30, 2020 8:00 AM ET
Company Participants
Joe Mara - Vice President, Investor Relations
Michel Vounatsos - Chief Executive Officer
Alfred Sandrock, Jr. - Executive Vice President, Research & Development and Chief Medical Officer
Jeffrey Capello - Executive Vice President and Chief Financial Officer
Conference Call Participants
Geoff Porges - SVB Leerink
Terence Flynn - Goldman Sachs
Ronny Gal - Bernstein
Phil Nadeau - Cowen and Company
Umer Raffat - Evercore
Geoff Meacham - Bank of America
Michael Yee - Jefferies
Cory Kasimov - JPMorgan
Matthew Harrison - Morgan Stanley
Jay Olson - Oppenheimer
Evan Seigerman - Credit Suisse
Robyn Karnauskas - SunTrust
Operator
Good morning. My name is Carmen, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Fourth Quarter and Full Year 2019 Financial Results and Business Update. [Operator Instructions]
Thank you. I would now like to turn the conference over to Mr. Joe Mara, Vice President, Investor Relations. You may begin.
Joe Mara
Good morning, and welcome to Biogen's fourth quarter 2019 earnings call. Before we begin, I encourage everyone to go to the Investors section of the biogen.com to find the earnings release and related financial tables, including a reconciliation of the GAAP to non-GAAP financial measures that we will discuss today. Our GAAP financials are provided in Tables 1 and 2, and Table 3 includes a reconciliation of our GAAP to non-GAAP financial results. We believe non-GAAP financial results better represent the ongoing economics of our business and reflect how we manage the business internally. We have also posted our slides on our website that follow the discussions related to this call.
I would like to point out that we will be making forward-looking
- Read more current BIIB analysis and news
- View all earnings call transcripts